老年冠狀動(dòng)脈粥樣硬化患者應(yīng)用規(guī)范化二級(jí)預(yù)防遠(yuǎn)近期治療效果

王紅霞

DOI：10.16662/j.cnki.1674-0742.2017.11.041

[摘要] 目的 探討老年冠狀動(dòng)脈粥樣硬化患者應(yīng)用規(guī)范化二級(jí)預(yù)防的遠(yuǎn)近期治療效果。方法 隨機(jī)選取該院在2015年6月—2016年9月期間收治的110例老年冠狀動(dòng)脈粥樣硬化患者，隨機(jī)分為觀察組和對(duì)照組，每組55例。對(duì)照組給予常規(guī)性藥物治療，觀察組在對(duì)照組的基礎(chǔ)上給予規(guī)范性二級(jí)預(yù)防， 觀察兩組患者的血脂相關(guān)性指標(biāo)：血清甘油三酯（TG）、血清總膽固醇（TC）、高密度脂蛋白膽固醇（HDL-C）及低密度脂蛋白膽固醇（LDL-C），觀察兩組患者的生存質(zhì)量評(píng)分及其遠(yuǎn)期治療效果。 結(jié)果 經(jīng)過4周的治療后，觀察組患者治療后的TG和 TC水平分別為（1.6±0.3）mmol/L和（2.9±0.6）mmol/L，明顯低于對(duì)照組（2.4±0.8）mmol/L和（3.8±0.7）mmol/L， 差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；觀察組患者的遠(yuǎn)期治療總有效率達(dá)到94.55%，明顯高于對(duì)照組76.36%，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；遠(yuǎn)期SAQ評(píng)分比較，觀察組患者分值（86.7±9.1）分，明顯高于對(duì)照組（71.4±8.3）分，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。 結(jié)論 規(guī)范化二級(jí)預(yù)防對(duì)老年冠狀動(dòng)脈粥樣硬化患者具有良好的遠(yuǎn)近期治療效果，可有效提高患者的生活質(zhì)量。

[關(guān)鍵詞] 老年冠狀動(dòng)脈粥樣硬化；應(yīng)用效果；規(guī)范化二級(jí)預(yù)防；近期療效；遠(yuǎn)期療效

[中圖分類號(hào)] R542 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-0742（2017）04（b）-0041-03

Long-term and Short-term Treatment Effect of Standardized Secondary Prevention of Senile Patients with Atherosclerosis of Coronary Artery

WANG Hong-xia

Department of Geriatrics， Linyi Traffic Hospital， Linyi， Shandong Province， 276000 China

[Abstract] Objective To study the long-term and short-term treatment effect of standardized secondary prevention of senile patients with atherosclerosis of coronary artery. Methods 110 cases of senile patients with atherosclerosis of coronary artery admitted and treated in our hospital from June 2015 to September 2016 were random selected and divided into two groups with 55 cases in each， the control group were given the routine drug treatment， while the observation group were given the standardized secondary prevention on the basis of the control group， and the blood fat related indexes such as TG， TC， HDL-C and LDL-C of the two groups were observed and the quality of life score and long-term treatment effect of the two groups were observed. Results After four-week treatment， the TG and TC levels in the observation group were obviously lower than those in the control group[（1.6±0.3） mmol/L， （2.9±0.6）mmol/L vs （2.4±0.8）mmol/L， （3.8±0.7）mmol/L]， and the differences were statistically significant（P<0.05）， and the long-term effective rate in the observation group was obviously higher than that in the control group （94.55% vs 76.36%）， and the difference was statistically significant（P<0.05）， and the long-term SAQ in the observation group was obviously higher than that in the control group[（86.7±9.1）points vs （71.4±8.3）points]， and the difference was statistically significant（P<0.05）. Conclusion The long-term and short-term treatment effects of standardized secondary prevention of senile patients with atherosclerosis of coronary artery are good， which can effectively improve the quality of life of patients.

DOI：10.16662/j.cnki.1674-0742.2017.11.041

[摘要] 目的 探討老年冠狀動(dòng)脈粥樣硬化患者應(yīng)用規(guī)范化二級(jí)預(yù)防的遠(yuǎn)近期治療效果。方法 隨機(jī)選取該院在2015年6月—2016年9月期間收治的110例老年冠狀動(dòng)脈粥樣硬化患者，隨機(jī)分為觀察組和對(duì)照組，每組55例。對(duì)照組給予常規(guī)性藥物治療，觀察組在對(duì)照組的基礎(chǔ)上給予規(guī)范性二級(jí)預(yù)防， 觀察兩組患者的血脂相關(guān)性指標(biāo)：血清甘油三酯（TG）、血清總膽固醇（TC）、高密度脂蛋白膽固醇（HDL-C）及低密度脂蛋白膽固醇（LDL-C），觀察兩組患者的生存質(zhì)量評(píng)分及其遠(yuǎn)期治療效果。 結(jié)果 經(jīng)過4周的治療后，觀察組患者治療后的TG和 TC水平分別為（1.6±0.3）mmol/L和（2.9±0.6）mmol/L，明顯低于對(duì)照組（2.4±0.8）mmol/L和（3.8±0.7）mmol/L， 差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；觀察組患者的遠(yuǎn)期治療總有效率達(dá)到94.55%，明顯高于對(duì)照組76.36%，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；遠(yuǎn)期SAQ評(píng)分比較，觀察組患者分值（86.7±9.1）分，明顯高于對(duì)照組（71.4±8.3）分，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。 結(jié)論 規(guī)范化二級(jí)預(yù)防對(duì)老年冠狀動(dòng)脈粥樣硬化患者具有良好的遠(yuǎn)近期治療效果，可有效提高患者的生活質(zhì)量。

[關(guān)鍵詞] 老年冠狀動(dòng)脈粥樣硬化；應(yīng)用效果；規(guī)范化二級(jí)預(yù)防；近期療效；遠(yuǎn)期療效

[中圖分類號(hào)] R542 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-0742（2017）04（b）-0041-03

Long-term and Short-term Treatment Effect of Standardized Secondary Prevention of Senile Patients with Atherosclerosis of Coronary Artery

WANG Hong-xia

Department of Geriatrics， Linyi Traffic Hospital， Linyi， Shandong Province， 276000 China

[Abstract] Objective To study the long-term and short-term treatment effect of standardized secondary prevention of senile patients with atherosclerosis of coronary artery. Methods 110 cases of senile patients with atherosclerosis of coronary artery admitted and treated in our hospital from June 2015 to September 2016 were random selected and divided into two groups with 55 cases in each， the control group were given the routine drug treatment， while the observation group were given the standardized secondary prevention on the basis of the control group， and the blood fat related indexes such as TG， TC， HDL-C and LDL-C of the two groups were observed and the quality of life score and long-term treatment effect of the two groups were observed. Results After four-week treatment， the TG and TC levels in the observation group were obviously lower than those in the control group[（1.6±0.3） mmol/L， （2.9±0.6）mmol/L vs （2.4±0.8）mmol/L， （3.8±0.7）mmol/L]， and the differences were statistically significant（P<0.05）， and the long-term effective rate in the observation group was obviously higher than that in the control group （94.55% vs 76.36%）， and the difference was statistically significant（P<0.05）， and the long-term SAQ in the observation group was obviously higher than that in the control group[（86.7±9.1）points vs （71.4±8.3）points]， and the difference was statistically significant（P<0.05）. Conclusion The long-term and short-term treatment effects of standardized secondary prevention of senile patients with atherosclerosis of coronary artery are good， which can effectively improve the quality of life of patients.

DOI：10.16662/j.cnki.1674-0742.2017.11.041

[摘要] 目的 探討老年冠狀動(dòng)脈粥樣硬化患者應(yīng)用規(guī)范化二級(jí)預(yù)防的遠(yuǎn)近期治療效果。方法 隨機(jī)選取該院在2015年6月—2016年9月期間收治的110例老年冠狀動(dòng)脈粥樣硬化患者，隨機(jī)分為觀察組和對(duì)照組，每組55例。對(duì)照組給予常規(guī)性藥物治療，觀察組在對(duì)照組的基礎(chǔ)上給予規(guī)范性二級(jí)預(yù)防， 觀察兩組患者的血脂相關(guān)性指標(biāo)：血清甘油三酯（TG）、血清總膽固醇（TC）、高密度脂蛋白膽固醇（HDL-C）及低密度脂蛋白膽固醇（LDL-C），觀察兩組患者的生存質(zhì)量評(píng)分及其遠(yuǎn)期治療效果。 結(jié)果 經(jīng)過4周的治療后，觀察組患者治療后的TG和 TC水平分別為（1.6±0.3）mmol/L和（2.9±0.6）mmol/L，明顯低于對(duì)照組（2.4±0.8）mmol/L和（3.8±0.7）mmol/L， 差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；觀察組患者的遠(yuǎn)期治療總有效率達(dá)到94.55%，明顯高于對(duì)照組76.36%，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）；遠(yuǎn)期SAQ評(píng)分比較，觀察組患者分值（86.7±9.1）分，明顯高于對(duì)照組（71.4±8.3）分，差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。 結(jié)論 規(guī)范化二級(jí)預(yù)防對(duì)老年冠狀動(dòng)脈粥樣硬化患者具有良好的遠(yuǎn)近期治療效果，可有效提高患者的生活質(zhì)量。

[關(guān)鍵詞] 老年冠狀動(dòng)脈粥樣硬化；應(yīng)用效果；規(guī)范化二級(jí)預(yù)防；近期療效；遠(yuǎn)期療效

[中圖分類號(hào)] R542 [文獻(xiàn)標(biāo)識(shí)碼] A [文章編號(hào)] 1674-0742（2017）04（b）-0041-03

Long-term and Short-term Treatment Effect of Standardized Secondary Prevention of Senile Patients with Atherosclerosis of Coronary Artery

WANG Hong-xia

Department of Geriatrics， Linyi Traffic Hospital， Linyi， Shandong Province， 276000 China

[Abstract] Objective To study the long-term and short-term treatment effect of standardized secondary prevention of senile patients with atherosclerosis of coronary artery. Methods 110 cases of senile patients with atherosclerosis of coronary artery admitted and treated in our hospital from June 2015 to September 2016 were random selected and divided into two groups with 55 cases in each， the control group were given the routine drug treatment， while the observation group were given the standardized secondary prevention on the basis of the control group， and the blood fat related indexes such as TG， TC， HDL-C and LDL-C of the two groups were observed and the quality of life score and long-term treatment effect of the two groups were observed. Results After four-week treatment， the TG and TC levels in the observation group were obviously lower than those in the control group[（1.6±0.3） mmol/L， （2.9±0.6）mmol/L vs （2.4±0.8）mmol/L， （3.8±0.7）mmol/L]， and the differences were statistically significant（P<0.05）， and the long-term effective rate in the observation group was obviously higher than that in the control group （94.55% vs 76.36%）， and the difference was statistically significant（P<0.05）， and the long-term SAQ in the observation group was obviously higher than that in the control group[（86.7±9.1）points vs （71.4±8.3）points]， and the difference was statistically significant（P<0.05）. Conclusion The long-term and short-term treatment effects of standardized secondary prevention of senile patients with atherosclerosis of coronary artery are good， which can effectively improve the quality of life of patients.